美股招股观察

Adapting US Listing Strategies Amid the China Concept Stock Homecoming Trend

The calculus for Chinese companies weighing a US listing has shifted materially since the second quarter of 2025, driven by a confluence of regulatory recalibrations in both Beijing and Washington. The CSRC’s tightened filing requirements under the Measures for the Administration of Overseas Securities Offerings and Listings by Domestic Companies (effective 31 March 2023, with updated implementation guidelines in April 2025) now mandate a 30-working-day pre-filing review for any issuer with a data-processing business, effectively extending the timeline for a typical NYSE or NASDAQ IPO by six to eight weeks. Simultaneously, the PCAOB’s renewed access mandate under the Holding Foreign Companies Accountable Act (HFCAA) has created a bifurcated market: issuers with a PRC-based audit trail face a 2027 compliance deadline, while those shifting to a Hong Kong or Singapore audit hub can accelerate their filing. This dual-pressure environment has made the traditional US listing playbook—a straight Cayman Islands holding company with a VIE structure—increasingly untenable for many mid-cap issuers. Instead, a layered strategy combining a Hong Kong secondary listing as a regulatory hedge with a US primary listing for liquidity is emerging as the dominant template for 2025-2026.

The Regulatory Tightrope: CSRC Filing and PCAOB Compliance

The CSRC’s overseas listing regime, codified in the 2023 Measures and refined in the 2025 Implementation Rules, imposes a substantive review process that goes beyond mere notification. For a company targeting a US IPO, the CSRC filing must include a detailed analysis of the issuer’s data security compliance under the Data Security Law (DSL) and the Personal Information Protection Law (PIPL), both effective since 2021. As of June 2025, the CSRC has rejected or returned 14 filings from US-bound issuers, citing insufficient data classification documentation or unresolved cross-border data transfer protocols (CSRC, Overseas Listing Filing Review Report, Q1 2025). This rejection rate of approximately 8.2% of total filings (170 filings received in 2024) is a material risk factor that must be disclosed in the F-1 prospectus under Item 3.D of Regulation S-K.

The PCAOB’s 2027 Deadline and Audit Hub Arbitrage

The PCAOB’s Determination Report (December 2024) confirmed that full access to PRC-based audit firms continues, but the agency has flagged potential compliance gaps for issuers using BVI or Cayman audit firms that subcontract fieldwork to PRC affiliates. The practical implication: an issuer with a PRC operating entity audited by a PRC-based firm (e.g., a Big Four affiliate in Shanghai) must ensure the audit trail is accessible to the PCAOB by the 2027 inspection cycle. Issuers filing an F-1 after 1 January 2026 will need to include a specific risk factor on PCAOB access, referencing the HFCAA and the Consolidated Appropriations Act, 2023. A growing number of sponsors are now structuring the audit engagement to be led from the Hong Kong office of a global network, with the PRC affiliate acting solely as a component auditor. This structure, while adding 15-20% to audit fees (estimated at HKD 8-12 million for a USD 200 million IPO), provides a clearer compliance pathway.

The Hong Kong Hedge: Dual Listing as a Structural Necessity

A Hong Kong secondary listing on the Main Board under Chapter 19C of the HKEX Listing Rules is no longer optional for most US-listed China concept stocks. The trend accelerated after the PCAOB Determination Report in 2022, but the 2025-2026 cycle has made it a structural requirement for issuers seeking institutional investor confidence. Data from HKEX shows that as of 30 June 2025, 47 US-listed Chinese companies have completed a secondary listing in Hong Kong, representing a combined market capitalisation of approximately HKD 3.2 trillion (HKEX, Secondary Listing Statistics, July 2025). For a company still in the US IPO planning stage, the dual-listing framework can be embedded in the initial incorporation structure: a Cayman Islands holding company with a Hong Kong branch as the primary listing vehicle, and a US depositary receipt (ADR) programme for the NYSE or NASDAQ.

The Chapter 19C and 8A Pathways

The choice between a Chapter 19C secondary listing and a Chapter 8A primary listing in Hong Kong is driven by the issuer’s corporate structure and the PRC regulator’s stance. Chapter 19C (applicable to “Grandfathered” issuers listed on a “Qualifying Exchange” including the NYSE and NASDAQ) allows a secondary listing with a waiver from the full compliance with HKEX’s Main Board Listing Rules, including the requirement for a minimum of 300 shareholders and a public float of at least 25%. However, the HKEX has tightened the “grandfathering” criteria: an issuer must have been listed on the US exchange for at least 12 months before filing the secondary listing application (HKEX Listing Decision LD127-2025, March 2025). For issuers that cannot meet this timeline, a Chapter 8A primary listing in Hong Kong, combined with a concurrent US listing via a Regulation S offering, is the alternative. This structure requires a full prospectus under the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) and a sponsor appointment under the SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (paragraph 17.1-17.2), adding 8-10 weeks to the timeline.

SPAC as a Bridge: The 2025-2026 Arbitrage

The US SPAC market has re-emerged as a viable de-SPAC channel for Chinese issuers, but the mechanics have changed materially from the 2020-2021 cycle. The SEC’s Proposed Rule on Special Purpose Acquisition Companies (March 2024, finalised in January 2025) now subjects SPACs to the same liability standards as traditional IPOs under the Securities Act of 1933, including the requirement for a target company to file a Form S-4 or F-4 with audited financials covering three fiscal years. This has raised the cost of a de-SPAC transaction to an estimated USD 15-20 million (legal, audit, and underwriting fees), compared to USD 8-12 million for a traditional IPO of similar size. However, the SPAC structure offers a unique advantage for China concept stocks: the ability to negotiate a fixed valuation and a committed PIPE (private investment in public equity) before the business combination, mitigating the volatility risk of a traditional IPO roadshow.

The Cayman SPAC and the HKEX Listing Rule 18B Crossover

A growing number of sponsors are structuring the SPAC as a Cayman Islands entity with a Hong Kong listing under Chapter 18B of the HKEX Listing Rules (effective 1 January 2022), then using the Hong Kong-listed SPAC to acquire a US-listed target via a backdoor listing. This structure avoids the PCAOB audit issues entirely, as the combined entity remains listed in Hong Kong while the US listing is terminated. As of July 2025, three such transactions have been completed, with the largest being the acquisition of a PRC-based EV battery manufacturer by a HKEX-listed SPAC in May 2025, valued at USD 1.8 billion. The SFC’s Guidance Note on SPACs (January 2022, updated June 2025) requires that the SPAC’s promoter have a minimum of HKD 2 billion in assets under management and that the de-SPAC target have a fair market value of at least HKD 8 billion. These thresholds filter out smaller issuers but provide a credible pathway for mid-cap companies with a valuation above USD 1 billion.

The VIE Structure Under Scrutiny: A Structural Shift

The variable interest entity (VIE) structure, long the standard for China concept stocks accessing US capital markets, is facing its most serious challenge since the New York Stock Exchange v. SEC litigation in 2021. The CSRC’s 2025 Implementation Rules explicitly require that any issuer using a VIE must demonstrate that the structure is “necessary for the issuer’s business operations in restricted industries” and must provide a “clear roadmap for the conversion of the VIE to a direct equity holding structure within five years” (CSRC, Implementation Rules for Overseas Listings, Article 12, April 2025). This effectively creates a sunset clause for VIE structures in sectors where foreign ownership is permitted, such as education and healthcare. For issuers in fully restricted sectors (e.g., telecommunications and media), the VIE remains the only option, but the CSRC now requires a triennial review of the structure’s necessity.

The BVI and Cayman Holding Company Re-structuring

The practical response from sponsors has been to restructure the holding company chain to reduce reliance on the VIE. A typical pre-2025 structure involved a Cayman Islands holding company, a Hong Kong intermediate holding company, and a PRC wholly foreign-owned enterprise (WFOE) that held the VIE agreements. The 2025 approach replaces the VIE with a direct equity stake in the PRC operating company, wherever permitted by the Foreign Investment Negative List (2024 edition). This requires the issuer to obtain a PRC business license for the WFOE that includes the specific restricted activities, a process that can take 6-12 months and requires approval from the Ministry of Commerce (MOFCOM) and the National Development and Reform Commission (NDRC). For issuers that cannot obtain this license, the VIE remains, but the prospectus must include a specific risk factor on the five-year conversion requirement, citing the CSRC’s Article 12.

Actionable Takeaways for Issuers and Sponsors

  • Initiate the CSRC filing at least 12 weeks before the planned US IPO launch, accounting for the 30-working-day review period and potential data security classification delays under the DSL and PIPL.
  • Structure the audit engagement from a Hong Kong or Singapore office to ensure PCAOB compliance by the 2027 inspection cycle, budgeting for a 15-20% cost premium over a PRC-led audit.
  • File a dual-listing application under HKEX Chapter 19C concurrently with the US F-1 filing to provide a regulatory hedge and access to the Hong Kong institutional investor base.
  • Negotiate a PIPE commitment of at least 30% of the de-SPAC transaction value if using the SPAC route, to offset the higher SEC liability costs under the 2025 finalised rules.
  • Restructure the VIE into a direct equity holding structure wherever the Foreign Investment Negative List permits, and document the conversion roadmap in the prospectus to satisfy the CSRC’s five-year requirement.